Literature DB >> 9401330

Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension.

J M Halperin1, J H Newcorn, V H Koda, L Pick, K E McKay, P Knott.   

Abstract

OBJECTIVE: To examine noradrenergic (NA) function in children with attention-deficit hyperactivity disorder (ADHD) by replicating and expanding upon a previous finding that ADHD children with and without reading disabilities (RD) differ in plasma levels of the NA metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG).
METHOD: Plasma levels of MHPG were compared in ADHD children who were subdivided on the basis of the presence or absence of RD. Subsequently, this replication sample was combined with a previously studied sample to further explore the relationship between plasma MHPG levels and measures of cognitive function in children with ADHD.
RESULTS: Plasma levels of MHPG were significantly lower in ADHD children without RD, compared with those with RD, replicating a published finding. Analyses in the combined sample indicated that, among children with ADHD, plasma MHPG levels were inversely associated with measures of academic achievement and verbal processing, but not parent or teacher ratings of behavior or continuous performance test measures of attention and impulsivity.
CONCLUSIONS: These data indicate that children with ADHD are not homogeneous with regard to NA function and that neurochemical variation is closely associated with differences in clinical characteristics of the children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401330     DOI: 10.1097/00004583-199712000-00017

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  6 in total

1.  Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.

Authors:  C L Barr; K Wigg; G Zai; W Roberts; M Malone; R Schachar; R Tannock; J L Kennedy
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

2.  Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.

Authors:  Tursun Alkam; Takayoshi Mamiya; Nami Kimura; Aya Yoshida; Daisuke Kihara; Yuki Tsunoda; Yuki Aoyama; Masayuki Hiramatsu; Hyoung-Chun Kim; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2017-03-23       Impact factor: 4.530

3.  Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows.

Authors:  Tursun Alkam; Hyoung-Chun Kim; Takayoshi Mamiya; Kiyofumi Yamada; Masayuki Hiramatsu; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2013-06-23       Impact factor: 4.530

4.  Time perception: does it distinguish ADHD and RD children in a clinical sample?

Authors:  R McGee; D Brodeur; D Symons; B Andrade; C Fahie
Journal:  J Abnorm Child Psychol       Date:  2004-10

Review 5.  Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.

Authors:  David E Comings; Thomas J H Chen; Kenneth Blum; Julie F Mengucci; Seth H Blum; Brian Meshkin
Journal:  Theor Biol Med Model       Date:  2005-12-23       Impact factor: 2.432

6.  Differential Genetic Effect of the Norepinephrine Transporter Promoter Polymorphisms on Attention Problems in Clinical and Non-clinical Samples.

Authors:  Zsofia Nemoda; Nora Angyal; Zsanett Tarnok; Emma Birkas; Emese Bognar; Maria Sasvari-Szekely; Judit Gervai; Krisztina Lakatos
Journal:  Front Neurosci       Date:  2019-01-14       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.